Breast Cancer Survivors May Discontinue Heart Medication After Recovery, Study Finds

A new study suggests that breast cancer survivors who experienced heart complications due to treatment may be able to stop taking heart medication once their cardiac function recovers, without long-term risks.

The findings, presented at the European Society of Cardiology Congress in Munich, highlight that many patients who developed heart issues during or after cancer therapy can discontinue medication if their heart health stabilizes over time.

Researchers emphasize that the decision to stop treatment depends on individual recovery outcomes, which are typically monitored through regular medical assessments. Most participants in the study did not require ongoing heart medication beyond a certain point.

The study adds to growing evidence that heart function in some cancer survivors can improve significantly, allowing for adjustments in post-treatment care.

Based on reporting from Medical Xpress (Cancer).

Source: Medical Xpress (Cancer). This article was drafted by AI from that reporting and reviewed by an automated accuracy check before publishing.